S.M.A.I.O appears in FDA device records as the applicant for the KHEIRON® Spinal Fixation System, including patient specific K-ROD, a Class II thoracolumbosacral pedicle screw system under 21 CFR 888.3070 and product code NKB. The company's published instructions for use identify S.M.A.I.O at 2, Place Berthe Morisot, Parc Technologique, 69800 Saint-Priest, France, as the manufacturer contact. The documented technology is a spinal fixation implant family with rods, including a patient specific rod variant, described in manufacturer documentation as non-sterile implants. [1][4][9]
Documented product identity and classification
FDA records describe the KHEIRON® Spinal Fixation System, including patient specific K-ROD, as a thoracolumbosacral pedicle screw system in Class II, regulation 21 CFR 888.3070, product code NKB. A separate FDA clearance letter for K260786 lists the same trade name and adds product code KWP alongside NKB. The manufacturer's instructions for use title the device as the KHEIRON® Spinal Fixation System including patient specific K-ROD and describe the implants as non-sterile. [1][4][9]
The KHEIRON® Spinal Fixation System – KROD rods instructions for use carry a statement of intended use for the KHEIRON device and are marked for use only in the United States of America. The same document carries the federal restriction limiting sale to or on the order of a licensed health practitioner. [3]
Filing record and dated examples
The linked 510(k) record for K262828 shows a submission received August 10, 2026, with a substantially equivalent decision dated September 4, 2026, under review by the Orthopedic advisory committee. The applicant of record is S.M.A.I.O, with a filing address in Saint-Priest, France, and the clearance type is listed as Special. [1]
A second FDA clearance letter, K260786, carries an April 3, 2026 letter date and March 10, 2026 Dated and Received submission fields, and addressed to S.M.A.I.O care of Robert A. Poggie, President, BioVera, Inc., at a Canadian address. That letter covers the KHEIRON® Spinal Fixation System, including patient specific K-ROD, and lists indications spanning chronic instabilities or deformities of the thoracic, lumbar and sacral spine. [9]
Manufacturer documentation and distribution references
Several versions of the KHEIRON® Spinal Fixation System including patient specific K-ROD instructions for use are published with revision dates in 2026, including revisions dated 09-2026 and 02-2026. These documents identify S.M.A.I.O in Saint-Priest, France, as the manufacturer contact and provide a customer service email address and website. [4][5][6][7]
Footnotes in those instructions for use point readers to separate parties for additional documentation: one revision references the NuVasive website, another references the Orthofix website, and each directs requests to S.M.A.I.O contact addresses. These references appear as documentation channels in the manufacturer's own text, not as statements of ownership or corporate structure. [4][6]
An archived revision of the KHEIRON Spinal Fixation System – KROD rods instructions for use, dated 08-2025, carries symbol definitions citing MDD 93/42/CE Annex XII for CE marking, while later revisions cite ISO 15223-1 symbols. The documents also state that use of the device must be reported to S.M.A.I.O and to the FDA. [4][8]
What the record does and does not establish
The linked collection contains one 510(k) record, K262828, with a substantially equivalent decision, and the record sample reflects that single entry. This is an as-of view of the linked filings, not a measure of total company sales, total portfolio or safety performance. No recall records appear in the linked sample. [1]
The FDA filing address in Saint-Priest is the address of record on the submission and matches the manufacturer contact in the instructions for use; it is not treated here as a verified corporate headquarters. Ownership, parent relationships and commercial availability in the United States are not established by the linked records. [1][4]



